CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $13.5M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.54% more ownership
Funds ownership: 15.59% → 21.13% (+5.5%)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.26M | |
| 2 | +$1.46M | |
| 3 | +$626K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$280K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$256K |
Top Sellers
| 1 | -$103K | |
| 2 | -$24K | |
| 3 | -$2.09K | |
| 4 |
CA
Calton & Associates
Tampa,
Florida
|
-$1K |